Skip to main content
Hikma Pharmaceuticals PLC (LON:HIK)
London flag London · Delayed Price · Currency is GBP · Price in GBp
2,130.00
-18.00 (-0.84%)
May 29, 2025, 6:10 PM BST

Hikma Pharmaceuticals Revenue

In the year 2024, Hikma Pharmaceuticals had annual revenue of $3.13B USD with 8.77% growth. Hikma Pharmaceuticals had revenue of $1.56B in the half year ending December 31, 2024, with 19.48% growth.

Revenue
$3.13B
Revenue Growth
+8.77%
P/S Ratio
1.88
Revenue / Employee
$329.16K
Employees
9,500
Market Cap
4.70B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.13B252.00M8.77%
Dec 31, 20232.88B358.00M14.22%
Dec 31, 20222.52B-36.00M-1.41%
Dec 31, 20212.55B212.00M9.06%
Dec 31, 20202.34B134.00M6.07%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
HUTCHMED (China) 503.39M
Genus 671.60M
Oxford Nanopore Technologies 183.19M
Revenue Rankings

Hikma Pharmaceuticals News

More News